Plasminogen Activation System in Rectal Adenocarcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Rectal adenocarcinoma is a significant cause of cancer mortality.
• The plasminogen activation system plays a role in tumor progression and metastasis.
• Key components include urokinase plasminogen activator (uPA), its receptor (uPAR), plasminogen activating inhibitor-1 (PAI-1), and tissue plasminogen activator (tPA).

Purpose of the Study:

• To investigate the expression levels of uPA, uPAR, PAI-1, and tPA in primary rectal adenocarcinoma and lymph node metastases.
• To correlate these expression levels with clinical and pathological characteristics of the disease.

Main Methods:

• Immunohistochemical analysis of archival paraffin-embedded tissues from 108 rectal adenocarcinoma patients.
• Semi-quantitative evaluation of protein expression using the immunoreactive score.
• Correlation of protein expression with disease stage, histological grade, and survival data.

Main Results:

• Cytoplasmic expression of uPA, uPAR, PAI-1, and tPA was elevated in tumor and metastatic tissues compared to normal rectal tissue.
• Significant positive correlations were observed between PAI-1 and tPA, uPA and uPAR, and uPA and PAI-1.
• Patients with low to moderate uPA and uPAR expression exhibited higher overall survival rates than those with high expression.

Conclusions:

• Expression intensity of uPA and uPAR may serve as a prognostic indicator for survival in rectal adenocarcinoma patients.
• These proteins are potential biomarkers for predicting patient outcomes in rectal cancer.